Literature DB >> 7713799

Role of reactive O2 in phagocyte-induced hypermetabolism and pulmonary injury.

A A Vlessis1, D Bartos, P Muller, D D Trunkey.   

Abstract

Activated phagocytes possess an enormous capacity for O2 consumption via NADPH oxidase. NADPH oxidase partially reduces O2, forming superoxide (O2-). Host enzymes rapidly complete O2- reduction to H2O, leaving little trace of its prior existence. Our objectives were to estimate the magnitude of whole body phagocyte respiration and determine the contribution of NADPH-derived O2- to the ensuing phagocyte-induced pulmonary injury. These objectives were accomplished using specific inhibitors of NADPH oxidase, diphenyl iodonium (DPI) and di-2-thienyl iodonium (DTI). Guinea pigs received intravenous injections of DPI (3.5 mg/kg), DTI (7.5 mg/kg), or vehicle followed by phorbol myristate acetate (PMA). Phagocyte activation by PMA immediately increased whole body respiration from 13.6 to 16.1 ml O2.kg-1.min-1 (P < 0.05). DPI and DTI completely blocked the increase in respiration induced by PMA injection (P < 0.05). Baseline respiration was unchanged by the NADPH oxidase inhibitor alone. Likewise, there was no effect on the respiration of isolated heart and kidney mitochondria from animals receiving the inhibitor with or without PMA. DPI attenuated the pulmonary injury induced by PMA. DPI attenuated the pulmonary injury induced by PMA. The ratio of lung water weight to dry weight was lower (6.4 +/- 0.3 vs. 8.3 +/- 0.6) and arterial PO2 was higher (86 +/- 9 vs. 56 +/- 6 Torr) in animals receiving DPI plus PMA than in those receiving PMA alone. In conclusion, phagocyte activation in vivo increased total body respiration by approximately 18%. The burst in respiration is attributed to the phagocyte respiratory burst in which NADPH oxidase partially O2 to O2-.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713799     DOI: 10.1152/jappl.1995.78.1.112

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

Review 1.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.

Authors:  Qingshan Wang; Li Qian; Shih-Heng Chen; Chun-Hsien Chu; Belinda Wilson; Esteban Oyarzabal; Syed Ali; Bonnie Robinson; Deepa Rao; Jau-Shyong Hong
Journal:  Brain       Date:  2015-02-25       Impact factor: 13.501

3.  Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.

Authors:  Benjamin Gauter-Fleckenstein; Katharina Fleckenstein; Kouros Owzar; Chen Jiang; Júlio S Rebouças; Ines Batinic-Haberle; Zeljko Vujaskovic
Journal:  Free Radic Biol Med       Date:  2010-01-20       Impact factor: 7.376

4.  Microvascular oxygen consumption during sickle cell pain crisis.

Authors:  Carol A Rowley; Allison K Ikeda; Miles Seidel; Tiffany C Anaebere; Matthew D Antalek; Catherine Seamon; Anna K Conrey; Laurel Mendelsohn; James Nichols; Alexander M Gorbach; Gregory J Kato; Hans Ackerman
Journal:  Blood       Date:  2014-03-24       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.